Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Y Cheung

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Neoplasia (New York, N.Y.)|May 26, 2019
Telomere Trimming and DNA Damage as Signatures of High Risk NeuroblastomaEun Young Yu, Irene Y Cheung, Yi Feng, et al.
Oncotarget|December 2, 2015
Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoinBrian H Kushner, Irina Ostrovnaya, Irene Y Cheung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastomaJeffrey M Venstrom, Junting Zheng, Nabila Noor, et al.
Oncotarget|December 10, 2017
<i>MYCN</i>-amplified stage 2/3 neuroblastoma: excellent survival in the era of anti-G<sub>D2</sub> immunotherapyBrian H Kushner, Michael P LaQuaglia, Shakeel Modak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2020
B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic Small Round Cell Tumor and Other Peritoneal Tumors: Results of a Phase I StudyShakeel Modak, Pat Zanzonico, Milan Grkovski, et al.
Oncoimmunology|September 18, 2018
Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I studyShakeel Modak, Jean-Benoit Le Luduec, Irene Y Cheung, et al.
JAMA|March 15, 2012
Association of age at diagnosis and genetic mutations in patients with neuroblastomaNai-Kong V Cheung, Jinghui Zhang, Charles Lu, et al.
Nature Genetics|May 11, 2023
Clonal evolution during metastatic spread in high-risk neuroblastomaGunes Gundem, Max F Levine, Stephen S Roberts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2022
Bone Marrow Surveillance of Pediatric Cancer Survivors Identifies Clones that Predict Therapy-Related LeukemiaBarbara Spitzer, Kayleigh D Rutherford, Gunes Gundem, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Neoplasia (New York, N.Y.)|May 26, 2019
Telomere Trimming and DNA Damage as Signatures of High Risk NeuroblastomaEun Young Yu, Irene Y Cheung, Yi Feng, et al.
Oncotarget|December 2, 2015
Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoinBrian H Kushner, Irina Ostrovnaya, Irene Y Cheung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastomaJeffrey M Venstrom, Junting Zheng, Nabila Noor, et al.
Oncotarget|December 10, 2017
<i>MYCN</i>-amplified stage 2/3 neuroblastoma: excellent survival in the era of anti-G<sub>D2</sub> immunotherapyBrian H Kushner, Michael P LaQuaglia, Shakeel Modak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2020
B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic Small Round Cell Tumor and Other Peritoneal Tumors: Results of a Phase I StudyShakeel Modak, Pat Zanzonico, Milan Grkovski, et al.
Oncoimmunology|September 18, 2018
Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I studyShakeel Modak, Jean-Benoit Le Luduec, Irene Y Cheung, et al.
JAMA|March 15, 2012
Association of age at diagnosis and genetic mutations in patients with neuroblastomaNai-Kong V Cheung, Jinghui Zhang, Charles Lu, et al.
Nature Genetics|May 11, 2023
Clonal evolution during metastatic spread in high-risk neuroblastomaGunes Gundem, Max F Levine, Stephen S Roberts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2022
Bone Marrow Surveillance of Pediatric Cancer Survivors Identifies Clones that Predict Therapy-Related LeukemiaBarbara Spitzer, Kayleigh D Rutherford, Gunes Gundem, et al.
Pageof 5